Automated therapy treatment using virtual reality from technology company Oxford VR, has been published on the Future NHSX Collaboration Platform.
Part of the NHSX ‘Virtual reality as a psychological tool’ blueprint, it details how Oxford VR’s automated virtual reality therapy has been integrated into NHS IAPT Talking Therapy services.
The technology uses ‘immersive technology’ and ‘evidence-based’ science, using VR mental health treatment designed to improve patient outcomes and increase capacity.
The technology is said to be a ‘spinout’ from Oxford University’s Department of Psychiatry.
Barnaby Perks, Founding CEO of Oxford VR said of the development “We are immensely proud that Oxford VR’s automated therapy is exemplified in the latest NHSX GDE blueprint publication.”
“In these unprecedented times for mental healthcare, digital transformation will be central to building capacity. This is an important blueprint that NHS Trusts can turn to, for an evidence-based and highly scalable intervention, that is making a real-world impact and is based on years of rigorous research.”
The blueprint details the process of how to rollout virtual reality therapy and includes components such as a standard operating procedure, a digital strategy and a data sharing template.
Oxford VR automated therapy builds on two decades of research by Daniel Freeman, Professor of Clinical Psychology and NIHR Research Professor at Oxford University, investigating VR’s potential to create a powerful new psychological treatment.
Recently the company closed a £10 million Series A funding round. The company will use the funds to accelerate US expansion of its evidence-based and VRtherapy solution and to continue to expand its treatment pipeline, with potential to create powerful, automated psychological treatments that revolutionise the way people experience therapy.
